Interesting read. “...could potentially ....” “...can potentially....” Wait and see, but “now developing a potential IND-ready product” suggests marekting is underway.
Anytime I see the acronym “mRNA” it’s always a big red flag to me.....and from now on probably always will be.
This was a mouse trial, a long way from a product.
There was an article this morning about a vaccine trial with 20 humans here:
https://www.dailymail.com/health/article-16050863/pancreatic-cancer-vaccine-cyst-shrinkage.html
That DM article is based on the more scientific report here:
https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-25-2245/786404/First-in-human-testing-of-a-mutant-KRAS-vaccine?token=0f5ae4ba-eb16-42d6-a983-9984b5312839
“Research Article| July 16 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts...
“
And while looking for info on KRAS, I found this very short article in Wiki about mRNA-5671 abandoned in 2021...
https://en.wikipedia.org/wiki/MRNA-5671
“Cancer vaccine”
j/s oddly it’s pancreatic cancer day in media
Come a little closer, said the spider to the fly.